Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Chapet

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Diagnostic and Interventional Imaging|June 15, 2020
Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: Predictors of local recurrence volume and metastasis-free survivalM Maoui, C Gonindard-Melodelima, O Chapet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trialG Freyer, N Bossard, P Romestaing, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 31, 2013
Potential interest of developing an integrated boost dose escalation for stereotactic irradiation of primary prostate cancerC Udrescu, O Rouvière, C Enachescu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 27, 2011
[Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of acute toxicities in a French centre and a review of the literature]B De Bari, L Lestrade, T Chekrine, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 17, 2012
Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signatureJ-P Gérard, J Baulieux, J Doyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trialN Methy, L Bedenne, T Conroy, et al.
Urology|May 27, 2008
Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical resultsG Pasticier, O Chapet, L Badet, et al.
La Revue De Medecine Interne|January 31, 2002
[Anorectal neuroendocrine carcinoma and small cell carcinoma. Report of two cases]O Chapet, A Corcelle-Requin, L Padovani, et al.
Bulletin Du Cancer|August 10, 2001
[Local control in the management of cancer: a few thoughts]J P Gérard, O Chapet, M Cucherat, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 12, 2017
[Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]P Sargos, S Larré, O Chapet, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Diagnostic and Interventional Imaging|June 15, 2020
Candidates to salvage therapy after external-beam radiotherapy of prostate cancer: Predictors of local recurrence volume and metastasis-free survivalM Maoui, C Gonindard-Melodelima, O Chapet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Addition of oxaliplatin to continuous fluorouracil, l-folinic acid, and concomitant radiotherapy in rectal cancer: the Lyon R 97-03 phase I trialG Freyer, N Bossard, P Romestaing, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 31, 2013
Potential interest of developing an integrated boost dose escalation for stereotactic irradiation of primary prostate cancerC Udrescu, O Rouvière, C Enachescu, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|December 27, 2011
[Should the treatment of anal carcinoma be adapted in the elderly? A retrospective analysis of acute toxicities in a French centre and a review of the literature]B De Bari, L Lestrade, T Chekrine, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|November 17, 2012
Towards a "Lyon molecular signature" to individualize the treatment of rectal cancer. Prognostic analysis of a prospective cohort of 94 rectal cancers T1-2-3 Nx MO to be the basis of a molecular signatureJ-P Gérard, J Baulieux, J Doyen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2009
Surrogate end points for overall survival and local control in neoadjuvant rectal cancer trials: statistical evaluation based on the FFCD 9203 trialN Methy, L Bedenne, T Conroy, et al.
Urology|May 27, 2008
Salvage radiotherapy after high-intensity focused ultrasound for localized prostate cancer: early clinical resultsG Pasticier, O Chapet, L Badet, et al.
La Revue De Medecine Interne|January 31, 2002
[Anorectal neuroendocrine carcinoma and small cell carcinoma. Report of two cases]O Chapet, A Corcelle-Requin, L Padovani, et al.
Bulletin Du Cancer|August 10, 2001
[Local control in the management of cancer: a few thoughts]J P Gérard, O Chapet, M Cucherat, et al.
Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique|February 12, 2017
[Adjuvant radiotherapy for bladder cancer in patients with risk of locoregional recurrence: Who, what and how?]P Sargos, S Larré, O Chapet, et al.
Pageof 6